Physician profile

Stephenie Ann Sharp

Dentist · Lewisville, TX

NPI 1912257296

$235.72

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$26.01

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Centrix INC $66.25 2020
Zimmer Biomet Holdings, INC. $55.01 2019
Straumann USA LLC $45.00 2021
Kerr Corporation $29.55 2019
Cochlear Americas $14.01 2023 Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant
Philips North America LLC $13.90 2019
Biolase, INC. $12.00 2023 Waterlase Iplus

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Stephenie Ann Sharp

$235.72

in general payments reported 2019-2025

Years
2019-2023
Top company
Centrix INC

https://glasscript.com/doctor/358827/stephenie-ann-sharp

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.